Last updated on June 2019

A New Prognostic Model Based on Liver Volume for Hepatitis B Virus Related Acute on Chronic Liver Failure


Brief description of study

HBVrelated acuteonchronic liver failure (HBVACLF) deteriorates rapidly with a high short-term mortality, for which liver transplantation is the only confirmed and effective treatment at present. Early identification and accurate prognostic prediction may be the key to make clinical decision and improve survival rate. Several prognostic models including Child Pugh, MELD, CLIFSOFA, CLIFC ACLF and COSSHACLF score systems have been commonly used. However, these models were not always accurate for predicting and without including liver volume, which can non-invasively reflect the balance of structural collapse with hepatic regeneration and can predict the prognosis.

Clinical Study Identifier: NCT03977857

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.